Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

NCT02193958 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

AML
CMML
MDS

Interventions

DRUG: FF-10501-01

Sponsor

Fujifilm Pharmaceuticals U.S.A., Inc.